Picture of Kuros Biosciences AG logo

KURN — Kuros Biosciences AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Kuros Biosciences Receives FDA Clearance For Extending Commercial Indications Of Magnetos Putty

Dec 10 (Reuters) - Kuros Biosciences AG  KURN.S :
    * KUROS RECEIVES FDA 510(K) CLEARANCE FOR EXTENDING
COMMERCIAL
INDICATIONS OF MAGNETOS PUTTY IN UNITED STATES
    * PAVES WAY FOR COMMERCIAL EXPANSION INTO MORE CLINICAL
INDICATIONS IN ORTHOPEDIC SURGERY

Further company coverage:  KURN.S 

 (Reporting by Riham Alkousaa)
 ((Riham.Alkousaa@thomsonreuters.com;))

Recent news on Kuros Biosciences AG

See all news